Demodex in Children: What Parents Need to Know

Marina Ivakhnenko

July 28, 2026

Chalazion, Children and Demodex, Demodex Blepharitis, DEMODEX OVERVIEW, Pediatric Blepharitis, Pediatric Demodex, SYMPTOMS & SIGNS, Teen Acne vs Demodex

Demodex in children compared with healthy child controls, 52.9 percent against zero

It starts with a lump on an eyelid. It gets warm compresses, then antibiotic drops,
then possibly a small procedure, and for a few weeks everything is fine. Then another one
appears, on the other lid, and the cycle repeats. By the third or fourth episode most
parents have been told this is just something some children get.

Sometimes it is. But there is a well-documented reason a subset of these children keep
having lid lumps, keep having red crusted lash lines, and keep failing conventional
treatment, and almost nobody screens for it. This guide covers what the published evidence
actually shows about Demodex in children, when it is worth investigating,
and what changes when a mite protocol is adapted for a child.

Quick answer

Demodex mites are uncommon on healthy children, which is precisely why finding
them on a child matters.
Colonisation rises steadily with age and is close to
universal in older adults, but in healthy young children it is rare. In a prospective study
of 446 children with chalazia and 50 matched controls aged seven months to thirteen years,
mites were detected in 52.9% of the chalazia group and in none of the controls.
Detection was strongly associated with recurrent chalazia, with an odds ratio of 4.94. A
separate series of twelve children aged 2.5 to 11 with chronic blepharoconjunctivitis that
had failed conventional treatment found mites in every case. The practical implication is
narrow and useful: a child with recurrent or multiple chalazia, or with chronic lid
inflammation that has already failed standard care, warrants a lash examination for
Demodex. Treatment in children is lower-strength, adult-applied and clinician-led,
and it belongs with a paediatric ophthalmologist or dermatologist.

52.9% vs 0%
Mite detection in children with chalazia against matched
healthy child controls
OR 4.94
Odds of mite detection in recurrent chalazia, 95%
confidence interval 1.59 to 15.37
17-25% → 0.9%
Reported paediatric chalazia recurrence, against recurrence
after comprehensive mite treatment in that cohort

How common is Demodex in children?

Demodex in children is not normal the way it is normal in adults. Colonisation is strongly age-dependent. It
climbs through adolescence as sebaceous glands become active under androgen drive,
continues rising through adult life, and by the eighth decade is close to universal.
Healthy young children are the opposite end of that curve, and multiple prevalence studies
describe detection in healthy children as uncommon.

The control arm of the paediatric chalazia study makes the point starkly. Fifty
children matched for age and sex, sampled by the same operator with the same technique,
read by the same masked technician: zero positive. Whatever the true
background rate is in healthy children, it is low enough that a positive result in a
symptomatic child is a meaningful finding rather than an incidental one.

This is the opposite of the situation in adults, where finding mites proves almost
nothing and only density counts. With Demodex in children, presence itself carries weight. For the adult framing, see our
Demodex life cycle guide, which explains why adult protocols are measured in mite generations.

How Demodex in children presents at each age

How Demodex in children presents differently across three age bands
Children rarely describe eye discomfort the way adults do, so the presenting complaint is usually something a parent can see.

Demodex in children does not present the way it presents in adults. Children are poor historians about eye discomfort. They do not report grittiness or
burning in the words an adult uses, so complaints get overlooked and the presenting
problem is usually visible rather than described.

Under six: recurrent and multiple chalazia

The classic pattern is lid cysts that keep returning after treatment or drainage,
often several at once, and often pointing through the skin rather than the inner lid
surface. In the published cohort, mite detection was significantly associated with
recurrence, with multiple cysts, with skin-surface nodules and with meibomian gland
dysfunction.

Six to twelve: refractory blepharoconjunctivitis

Red lid margins, crusted lashes, chronic irritation and light sensitivity that has
already failed antibiotic drops and lid hygiene. This group matters because it is not
only cosmetic. In the twelve-child series, presentations included corneal infiltrates,
superficial punctate keratopathy, phlyctenular keratitis and in one case a corneal ulcer.
Paediatric blepharokeratoconjunctivitis is reported to run a more severe corneal course
than the adult form, attributed largely to delayed diagnosis.

Teenagers: papules without comedones

Adolescence is when sebum production and mite colonisation both climb, and it is also
when every facial eruption gets labelled teenage acne. The features that argue against
that label are the same in a fifteen-year-old as in an adult: rough or frosted skin
texture, burning rather than tenderness, and an absence of blackheads and closed comedones.
Our guide to Demodex acne covers that
distinction in full.

Demodex in children: the chalazia evidence

Demodex detection in children with chalazia compared with matched controls
446 children with chalazia against 50 matched controls. The control column is the finding that matters.

The strongest dataset on Demodex in children is a prospective study from Guangzhou of 446 children
with chalazia and 50 controls undergoing surgery for strabismus or dermoid cysts, ages
seven months to thirteen years. Children on immunosuppressants and children with rosacea
were excluded. Three lashes were epilated per lid under anaesthesia and read by an
independent masked technician.

Mites were found in 236 of the 446 chalazia patients, 52.9%, and in none of the
controls. On multivariate analysis, two factors stood out: recurrent chalazia, with an odds
ratio of 4.94 and a 95% confidence interval of 1.59 to 15.37, and skin-surface rather than
conjunctival-surface nodules, at 1.65.

The follow-up number is the one that changes practice. Paediatric chalazia recurrence
is reported at 17 to 25%. In this cohort, after chalazia removal followed by comprehensive
mite treatment, only 0.9% required re-operation for recurrence. That is a single-cohort
observation without a randomised comparison, so it should be read as a strong signal rather
than as proof. It is still the most actionable finding in the paediatric literature.

Chronic red eyes that will not settle

The second key paper is smaller and older: twelve children aged 2.5 to 11 with chronic
blepharoconjunctivitis that had failed conventional treatment. Demodex was found in
every one. Ten had bilateral meibomian gland dysfunction and four had multiple recurrent
chalazia. Treated with tea tree oil lid scrubs or ointment massage over four to six weeks,
all showed marked resolution of irritation and inflammation within the first week, and all
corneal signs cleared within two weeks apart from one residual stromal scar. Over roughly
eight months of follow-up, one child had a recurrence that responded to a repeat course.

Twelve children is a small series and there was no control group, so it establishes
that the association exists and is treatable, not how common it is. What it does establish
well is that this belongs on the differential for a child whose red eyes have already
failed the standard pathway.

How Demodex in children is diagnosed

Demodex in children is diagnosed by lash sampling and light microscopy. A small number of lashes are
epilated, mounted on a slide and examined for adults, nymphs, larvae or eggs. In the
paediatric chalazia cohort, sampling was done under general anaesthesia because the
children were already undergoing surgery, and lashes near cysts, near visible cylindrical
dandruff or over dilated glands were prioritised to maximise yield.

Two points matter for parents assessing Demodex in children. First, sampling is a clinical procedure and not something
to attempt at home. Second, Demodex lays eggs deep in the follicle, so the mites
visible on an epilated lash under-represent the population; a low count is not a clean bill
of health. For context on how adult testing works, see our
clinical diagnosis guide and the
self-assessment
guide
, keeping in mind that both are written for adults.

What changes when treating Demodex in children

What changes when a Demodex protocol is adapted for a child
The biology is identical to an adult. The concentration, the supervision and who decides are not.

The mite biology in a seven-year-old is identical to the mite biology in a
forty-seven-year-old. Almost everything around treating Demodex in children is different. Where lid margin disease is the problem, our
Demodex blepharitis guide covers the adult version of the same territory.

Concentration. The published paediatric regimens use lower-strength,
clinician-applied preparations. The high-percentage in-office scrubs used in adult ocular
work are not a home product and are not appropriate for a child’s ocular surface. Where a
tea tree derivative is used, terpinen-4-ol, the isolated active fraction, is described in
the paediatric literature as preferred over whole tea tree oil because it carries a better
tolerability profile. Our
tea tree oil evidence guide
explains why the fraction and the whole oil behave differently.

Who applies it. An adult applies it, on a still and cooperative child,
with the eye closed, along the lash root rather than onto the eye. The published protocol
paired a warm compress at 40 to 45 degrees Celsius for 10 to 15 minutes with a
terpinen-4-ol wipe drawn along the lash roots for at least 30 seconds, followed by
metronidazole gel to the lash roots, twice daily.

Duration. Typically one to three months with monthly review, which is
shorter than most adult protocols but still spans several complete mite generations. Mean
treatment duration in the cohort was about 1.7 months.

Who decides. A paediatric ophthalmologist or dermatologist, before
anything is applied. Nothing on this page is a prescription, and no product should go near
a child’s eye without an examination first.

Red flags that outrank Demodex in children

Nothing about Demodex in children outranks basic eye safety. Take a child to an eye doctor promptly, rather than waiting, for any of the following.

Any change in vision, or a child squinting, closing one eye, or holding
things unusually close.

Marked light sensitivity, especially with a red eye.

A painful eye, as opposed to an itchy or irritated one.

Spreading redness or swelling of the lid or surrounding skin, or a
child who is unwell with it.

A lid lump that is growing quickly, or one that is not settling over
weeks.

These are general ophthalmic red flags rather than mite-specific ones, which is exactly
why they take priority. Investigating Demodex is a question for a child whose eye
is safe and whose problem is chronic and recurrent.

Can children catch Demodex from a parent?

Mites transfer through close and prolonged skin contact, and shared pillows and towels
are plausible routes. Parents ask this more than any other question about Demodex in children. What is not established is that ordinary household transfer causes
disease in a child with normal skin, and the low detection rate in healthy children argues
that a young child’s follicular environment does not readily sustain a population.

The sensible reading is that transfer is possible and susceptibility is the limiting
factor, which is why Demodex in children stays uncommon in households where an adult is affected. Where a household is managing an adult case, the general hygiene measures in our
Demodex maintenance guide are
reasonable, proportionate and worth doing anyway. Household panic is not.

For practitioners

With Demodex in children, the control arm is the finding. Zero of fifty age- and sex-matched
paediatric controls positive, against 52.9% of chalazia cases, inverts the usual adult
interpretive frame. In adults, presence is near-universal and only density discriminates.
In children, the Guangzhou group’s recommendation is that at least one mite per twelve
sampled lashes should be treated as positive and prompt intervention, precisely because
the background rate is so low.

Recurrence is the trigger to sample. On multivariate analysis, recurrent
chalazia carried an odds ratio of 4.94 (1.59 to 15.37, p = 0.006) and skin-surface nodules
1.65 (1.05 to 2.57, p = 0.029). Age, sex, laterality, disease duration, season and anterior
blepharitis were not discriminating. A first isolated chalazion does not need a lash
sample; a second or third does.

Sampling under-detects. Ova remain in the follicle after epilation, so
the count from an epilated lash is a floor. Only 9.75% of positive children in that cohort
reached 2 or more mites per 12 lashes, which is why an adult-style density threshold
performs poorly here.

Corneal risk is real in the paediatric group. The Liang series recorded
corneal infiltrates, superficial punctate keratopathy, phlyctenular keratitis and a corneal
ulcer among twelve children, and paediatric blepharokeratoconjunctivitis is reported to run
a more severe corneal course than the adult form, largely because of diagnostic delay.
Chronic paediatric lid disease deserves a slit-lamp examination, not a repeat
prescription.

Frequently asked questions

Can children get Demodex mites?

Yes. Demodex in children is uncommon in healthy children and becomes steadily more common with age.
In a matched paediatric control group of fifty healthy children, none tested positive,
while just over half of the children with chalazia did.

What are the signs of Demodex in a child?

Demodex in children most often shows up as recurrent or multiple eyelid cysts, red and crusted lash lines, rubbing and
blinking, light sensitivity, or chronic eye irritation that has already failed antibiotic
drops and lid hygiene. In teenagers it can present as papules with no blackheads and a
rough skin texture.

Is treating Demodex in children safe?

Adapted paediatric regimens have been used and reported in the ophthalmic literature,
using lower strengths, adult application and clinical supervision. Adult-strength products
and home experimentation near a child’s eye are not safe. This is a decision for a
paediatric ophthalmologist or dermatologist.

Why does my child keep getting styes and chalazia?

Recurrence has several causes, but mite infestation is one that is rarely screened for
and is strongly associated with the recurrent pattern specifically. It is a reasonable
question to raise with your eye doctor after a second or third episode.

Should the whole family be treated?

Not automatically. Transfer between close contacts is plausible and basic hygiene
measures are sensible, but treating asymptomatic family members is not standard practice
and should be a clinical decision rather than a default.

References

  1. Huang J, Guo MX, Xiang DM, et al. The association of Demodex infestation with pediatric
    chalazia. BMC Ophthalmology. 2022;22:124. PubMed identifier 35291979.
  2. Liang L, Safran S, Gao Y, Sheha H, Raju VK, Tseng SCG. Ocular demodicosis as a
    potential cause of pediatric blepharoconjunctivitis. Cornea. 2010;29(12):1386-1391. PubMed
    identifier 20847679.
  3. Liang L, Ding X, Tseng SCG. High prevalence of Demodex brevis infestation in chalazia.
    American Journal of Ophthalmology. 2014;157(2):342-348.
  4. Yam JCS, Tang BSM, Chan TM, et al. Ocular demodicidosis as a risk factor of adult
    recurrent chalazion. European Journal of Ophthalmology. 2014;24(2):159-163.
  5. Wesolowska M, Knysz B, Reich A, et al. Prevalence of Demodex spp. in eyelash follicles
    in different populations. Archives of Medical Science. 2014;10(2):319-324.
  6. Bhandari V, Reddy JK. Blepharitis: always remember Demodex. Middle East African Journal
    of Ophthalmology. 2014;21(4):317-320.
  7. Navel V, Mulliez A, Benoist d’Azy C, et al. Efficacy of treatments for Demodex
    blepharitis: a systematic review and meta-analysis. The Ocular Surface.
    2019;17(4):655-669.
  8. Chen D, Wang J, Sullivan DA, et al. Effects of terpinen-4-ol on meibomian gland
    epithelial cells in vitro. Cornea. 2020;39(12):1541-1546.
  9. Elston CA, Elston DM. Demodex mites. Clinics in Dermatology. 2014;32(6):739-743.
  10. Litwin D, Chen W, Dzika E, Korycinska J. Human permanent ectoparasites: recent advances
    on biology and clinical significance of Demodex mites. Iranian Journal of Parasitology.
    2017;12(1):12-21.

About the author. Marina Ivakhnenko is a
functional skin practitioner who works with chronic, relapsing Demodex-associated skin and
eyelid conditions, and writes the clinical education library at demodex.net/. This article is
educational and is not a substitute for individual medical assessment, diagnosis or
treatment. Speak to a qualified clinician before starting, stopping or changing any
therapy.

Written by Marina Ivakhnenko — licensed aesthetician, nutritionist and Functional Diagnostic Nutrition Practitioner (FDN-P), with a biology background from Florida Atlantic University. Author of The Demodex Solution.

She works with Ovante, a skincare brand formulating for Demodex-prone, rosacea-prone and folliculitis-prone skin since 1992, and created Rosacea Decoded, a program for rosacea and reactive skin.

Demodex.net is published by the team behind Ovante. Articles here are educational and are not a substitute for care from a physician or dermatologist.

DEMODEX QUIZ

Determine your mite density and get a personalized treatment protocol in 2 minutes.

JOIN OUR COMMUNITY

Connect with 15,000+ members in our private support group.

JOIN OUR COMMUNITY

Latest post

Chronic Inflammation, Demodex & Gut Health, Digestive Triggers, Food Sensitivities, Functional Medicine Evidence, Functional Testing, Gut Dysbiosis, Gut-Skin Axis, Leaky Gut, PubMed Research
Marina Ivakhnenko

●

November 4, 2026

Leaky Gut and Rosacea: What the Evidence Shows, and What to Test Instead

Leaky gut and rosacea: two small zonulin studies, a common
Bacterial vs Demodex, Demodex & Folliculitis, Demodex & Scalp Folliculitis, Demodex vs Folliculitis, Dermoscopy, Fungal vs Demodex, Itchy Scalp, Recurrent Folliculitis, Scalp Bumps, Scalp Symptoms, Severe Scalp Inflammation, Shampoo Protocols, Sulfur
Marina Ivakhnenko

●

November 4, 2026

Scalp Folliculitis: Nine Causes That Look the Same, and How to Tell Yours Apart

Scalp folliculitis is a pattern with at least nine causes.
Azelaic Acid, Clinical Trials, Demodex & Rosacea, DEMODEX & SKIN CONDITIONS, Demodex Diagnosis & Testing, Dermatology Studies, Dermoscopy, Ivermectin, Metronidazole, Papulopustular Rosacea, Persistent Redness, Prescription Therapies, Research & Clinical Studies, RESEARCH & SCIENCE, Rosacea Maintenance, Rosacea Relapse, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols
Marina Ivakhnenko

●

September 28, 2026

Ivermectin vs Metronidazole for Rosacea: Who Wins, and Who Needs Which

Ivermectin vs metronidazole is not a simple win. The head-to-head
Demodex & Autoimmune Conditions, Demodex & Immune Dysregulation, Demodex & Seborrheic Dermatitis, DEMODEX & SKIN CONDITIONS, Demodex Diagnosis & Testing, Demodex vs Contact Dermatitis, Demodex vs Seborrheic Dermatitis, Differential Diagnosis, Facial Symptoms, Functional Testing, Prescription Therapies, Skin Scraping, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, TREATMENT & PROTOCOLS, Unexplained Inflammation
Marina Ivakhnenko

●

September 28, 2026

Dupilumab Facial Redness: Yeast, Mite, or Something Else?

Dupilumab facial redness is not one condition. Yeast, Demodex mites,
Burning & Stinging, Chronic Failed Treatment, Demodex & Autoimmune Conditions, Demodex & Chronic Inflammation, Demodex & Perioral Dermatitis, Demodex & Rosacea, DEMODEX & SKIN CONDITIONS, FAQS & QUICK ANSWERS, Papulopustular Rosacea, Persistent Redness, Prescription Therapies, Red Flags & Doctor Referral, Rosacea Flushing, Rosacea Recovery, Rosacea Relapse, Steroid Rebound, Steroid-Induced Demodex, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols
Marina Ivakhnenko

●

September 8, 2026

Steroid Induced Rosacea: Why the Cream That Worked Is the Reason It Will Not Stop

Steroid induced rosacea is not the steroid masking a condition.
Chronic Perioral Flares, Demodex & Perioral Dermatitis, DEMODEX & SKIN CONDITIONS, Demodex vs Perioral Dermatitis, Differential Diagnosis, Facial Symptoms, Itchy Perioral Rash, Mouth Rash, Nose Fold Irritation, Persistent Redness, POD vs Rosacea, Prescription Therapies, Redness Around Mouth, Steroid Rebound, Symptoms & Clinical Signs, SYMPTOMS & SIGNS, TESTING & DIAGNOSIS, Topical Therapies, TREATMENT & PROTOCOLS, Treatment Protocols
Marina Ivakhnenko

●

September 8, 2026

Perioral Dermatitis Treatment: Why the Best Evidence Is for Stopping, Not Starting

The best-supported perioral dermatitis treatment is removing things, not adding